Search
for
Sort by
Research 91–120 of 142
- androgenetic alopecia, n.
- Alternative androgen pathways
- The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
- Role of Androgen Receptor in Hypothalamic Regulation of Metabolism and Reproduction
- [Treatment of moderately severe virilism of women with Diane and Androcur 10].
- [Differentiated application of oral contraceptives basing on the different side effects of synthetic progestins (author's transl)].
- [Comments on the paper: “Studies on the etiology of androgenetic alopecia in the female” by E. Vadász and M. Debreczeni (Hautarzt 18, 454-456, 1967)].
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Visually scoring hirsutism
- Hormonal Effects on Hair Follicles
- Current evaluation of amenorrhea
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Clinical biochemistry of dihydrotestosterone
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- Current evaluation of amenorrhea
- A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
- Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl
- Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
- Current evaluation of amenorrhea
- Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
- Spironolactone May Reduce the Risk of Incident Rosacea
- Second-to-fourth digit ratio and seborrheic dermatitis in males: a cross-sectional study*